Latest Breaking News On - Rebecca taub - Page 2 : comparemela.com

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Lowered to $381 00 at JMP Securities

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Lowered to $381 00 at JMP Securities
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPaula friedmanRebecca taubAnalyst recommendations for madrigal pharmaceuticalsInstitutional trading of madrigal pharmaceuticalsBain capital life sciences investorsMadrigal pharmaceuticals stock performanceNews ratings for madrigal pharmaceuticals dailyAvoro capital advisorsCanaccord genuity groupMadrigal pharmaceuticalsMadrigal pharmaceuticals incGet free reportGenuity groupDirector paulCapital advisors

Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Lowered to $390 00

Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Lowered to $390 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390 00

HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390 00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesJamesm dalyRebecca taubPiper sandlerPrincipal financial group incDana investment advisors incGlobal retirement partnersMadrigal pharmaceuticals stock performanceSecurities exchange commissionColumbus asset advisorsMadrigal pharmaceuticalsNews ratings for madrigal pharmaceuticals dailyMadrigal pharmaceuticals incAnalyst recommendations for madrigal pharmaceuticalsInstitutional investors weigh in on madrigal pharmaceuticalsInsider activity at madrigal pharmaceuticals

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $382 00 by Analysts at Citigroup

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $382 00 by Analysts at Citigroup
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRichards levyRebecca taubMadrigal pharmaceuticals incCanaccord genuity groupMontaga associates incAnalyst recommendations for madrigal pharmaceuticalsMadrigal pharmaceuticalsNews ratings for madrigal pharmaceuticals dailyGlobal retirement partnersSecurities exchange commissionInsider transactions at madrigal pharmaceuticalsMadrigal pharmaceuticals trading downChina universal asset management coGet free reportPharmaceuticals trading down

Madrigal Pharmaceuticals (MDGL) Scheduled to Post Earnings on Tuesday

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) will be releasing its earnings data before the market opens on Tuesday, May 7th. Analysts expect Madrigal Pharmaceuticals to post earnings of ($6.06) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Madrigal Pharmaceuticals (NASDAQ:MDGL – Get […]

United statesRebecca taubPiper sandlerRichards levyMadrigal pharmaceuticalsMadrigal pharmaceuticals stock downMadrigal pharmaceuticals incNews ratings for madrigal pharmaceuticals dailyEarnings history for madrigal pharmaceuticalsSecurities exchange commissionMadrigal pharmaceuticals company profileCanaccord genuity groupGet free reportPharmaceuticals stock downGenuity groupDirector richard